Search clinical trials for: FDG PET CT

Total 9365 results

Johns Hopkins University

Completed

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Ovarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
Grand River Hospital
St. Joseph's Healthcare Hamilton

Unknown

PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life (PEARL)

Prostate Cancer

Canada
King's College London
Guy's and St Thomas' NHS Foundation Trust

Suspended

Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT

Carotid Atherosclerosis

United Kingdom
Nationwide Children's Hospital
Ohio State University

Recruiting

Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Diabetes Mellitus | Peripheral Artery Disease | Chronic Limb-Threatening Ischemia

United States
Oslo University Hospital

Active, not recruiting

Dose Painting of Head and Neck Cancer (RADPAINT)

Head and Neck Cancer

Norway
Turku University Hospital

Recruiting

Brain Insulin Resistance in Mild Cognitive Impairment (COINS)

Alzheimer Disease | Mild Cognitive Impairment | Positron Emission Tomography

Finland
Radboud University Medical Center
UMC Utrecht; Amsterdam UMC, location VUmc; Maastro Clinic, The Netherlands; Rad...

Completed

Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity (UPGRADE-RT)

Head and Neck Neoplasms | Carcinoma, Squamous Cell

Netherlands
Oslo University Hospital
Norwegian Cancer Society

Active, not recruiting

ReIrradiation With FDG-PET Guided Dose Painting (RIDPAINT)

Head and Neck Cancer

Norway
Oslo University Hospital

Active, not recruiting

RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck (RADPAINT-2)

Head and Neck Cancer

Norway
prof. dr. Koen Van Laere
Universitaire Ziekenhuizen KU Leuven; KU Leuven; University Hospital, Ghent; Fund...

Not yet recruiting

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. AD

Parkinson Disease | Alzheimer Disease | Dementia With Lewy Bodies | MSA - Multiple System Atrophy

Belgium
Mayo Clinic

Completed

d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

Cardiac Sarcoidosis

United States
University of Cincinnati
National Cancer Institute (NCI); Ohio Third Frontier

Active, not recruiting

Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

PET/CT Imaging

United States
Universitaire Ziekenhuizen KU Leuven

Recruiting

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

Status Epilepticus | Positron-emission Tomography | Ictal-interictal Continuum | Perfusion Weighted MRI | Perfusion CT

Belgium
University Hospital, Montpellier

Completed

Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT (PREDISP)

Aneurysmal Subarachnoid Haemorrhage

France
Klinikum Bayreuth GmbH
Peking University Cancer Hospital & Institute; Sana Klinikum Hof

Completed

Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma (PANU)

NSCLC
University of Basel
University Hospital, Basel, Switzerland

Completed

Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma

Malignant Melanoma
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Stage IIIA Non-small Cell Lung Cancer
Washington University School of Medicine

Terminated

18F-FLT PET Imaging in Patients With Advanced Melanoma

Melanoma

United States
Rigshospitalet, Denmark

Recruiting

18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

Neuroblastoma

Denmark
Rambam Health Care Campus

Completed

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Classical Hodgkin Lymphoma | Nodular Sclerosis | Mixed Cellularity | Lymphocyte Depletion | Lymphocyte Rich

Israel
Sir Mortimer B. Davis - Jewish General Hospital

Terminated

SUV on PSMA PET/CT in Non-Prostate Tumors

Cancer

Canada
Washington University School of Medicine

Terminated

Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

Liver Neoplasms

United States
University of Oslo
Oslo University Hospital; Sunnaas Rehabilitation Hospital

Recruiting

Cognitive Function and Fatigue After Brain Abscess

Fatigue | Cognitive Dysfunction | Brain Abscess

Norway
Guy's and St Thomas' NHS Foundation Trust
Velindre NHS Trust

Completed

18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours (FiGaRO)

Oropharyngeal Cancer

United Kingdom
Centre Georges Francois Leclerc

Completed

Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET (TRANSTEP)

Breast Neoplasms

France
National Center for Research Resources (NCRR)

Unknown

Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging

Cystic Fibrosis

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Prostate Cancer

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET

Tuberculosis

United States
Wuerzburg University Hospital

Recruiting

PSMA in Gastrointestinal Tumors (GIPSMA, Focusing on Neuroendocrine Neoplasms) (GIPSMA)

Gastrointestinal Cancer

Germany
National Taiwan University Hospital

Recruiting

18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.

Biochemical Relapse Fo Malignant Neoplasm of Prostate

Taiwan
University of Utah

Recruiting

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy (PIONEER)

Esophageal Cancer

United States
Uppsala University

Recruiting

A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma (TRIM)

Malignant Melanoma

Sweden
University of Texas Southwestern Medical Center

Withdrawn

Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

Solid Tumor

United States
Mayo Clinic

Active, not recruiting

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Osteomalacia

United States
Institut Cancerologie de l'Ouest
ATONCO

Completed

Assessment of safEty, Tolerability, Radiation Dosimetry, and Imaging Properties of 89Zr-labeled giRenTuximab (89Zr-Girentuximab) in patIents With Non-musclE-iNvasive Bladder CancEr (NMIBC) (PERTINENCE)

Bladder Cancer

France
GE Healthcare

Active, not recruiting

Demonstration Of A Next Generation PET CT System

Oncology

Israel
Memorial Sloan Kettering Cancer Center

Completed

A Study to Assess Thymic Function Using PET/CT and MRI

CD34 Selected Peripheral Blood Stem Cell Graft

United States
Isala
Philips Healthcare

Completed

Intra-individual Comparison of Conventional and Digital PET/CT Scanners

Breast Cancer | Esophageal Cancer | Lung Cancer | Miscellaneous Neoplasm

Netherlands
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Breast Cancer | Breast Neoplasms | Breast Cancer, Male | Breast Cancer, Female

United States
University of Utah
Huntsman Cancer Institute

Not yet recruiting

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Hypoxia | Head and Neck Cancer | Magnetic Resonance Imaging | Cancer Neck
The First Affiliated Hospital of Xiamen University

Recruiting

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Ovarian Cancer

China
Imperial College London

Recruiting

Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT

Metastatic Renal Cell Carcinoma

United Kingdom
University of Strathclyde
NHS Greater Glasgow and Clyde

Recruiting

Correlation of Pre- and Post-operative Cancer Imaging Techniques

Lung Cancer

United Kingdom
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Molecular Imaging of Solid Tumors

Gastrointestinal Tumors

China
Peking University Cancer Hospital & Institute

Recruiting

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Solid Tumor

China
Zhejiang University

Completed

A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Systemic Treatment | 18F-FAPI | Pathologic Response

China
University of Cincinnati
Ohio Third Frontier

Active, not recruiting

Feasibility Assessment of Next-generation PET Technology and Procedures

New-generation Digital PET/CT Imaging

United States
Jewish General Hospital

Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Neuroendocrine Tumors

Canada

Search clinical trials for: FDG PET CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations